CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Grant or award Pieper Steven acquired 200,000 shares (grant or award)
- 4 Grant or award JOHNSON KENNETH ERLAND acquired 75,000 shares (grant or award)
- 4 Grant or award Hecht Beth acquired 225,000 shares (grant or award)
- 4 Grant or award Shannon John Patrick Jr acquired 250,000 shares (grant or award)
- 4 Grant or award Edick Paul R acquired 600,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 75,000 shares (grant or award)
- 4 Open-market buy Edick Paul R bought 20,000 shares at $2.28 ($45,664)
- 4 Open-market buy Shannon John Patrick Jr bought 100,000 shares at an average $2.10 ($209,500)
- 4 Open-market buy Edick Paul R bought 200,000 shares at $2.08 ($415,760)
- 4 Open-market buy Pieper Steven bought 25,000 shares at $2.00 ($49,918)
- 4/A Grant or award Director acquired 50,170 shares (grant or award)
- 4/A Grant or award Director acquired 478,312 shares (grant or award)
- 4 Grant or award Director acquired 50,170 shares (grant or award)
- 4 Grant or award Director acquired 478,312 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Edick Paul R acquired 621,494 shares (grant or award)
- 4 Grant or award Shannon John Patrick Jr acquired 263,829 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 494,780 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 9 · 178 filings